CClinicalTrials.gg
RecruitingNCT07435831Updated Apr 2, 2026

Kimchi and Gut Health

An interventional study of 60 grams per day of intervention food and 60 grams per day of intervention food in Healthy Adult Participants, sponsored by University of California, Davis. Recruiting at 2 sites in United States. Open to participants aged 19 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by University of California, Davis · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years to 70 Years
Sex
All
01

Study summary

The goal of this study is to learn about the effects of eating kimchi on the gut health of healthy adults in the USA. The investigators will be researching the changes in the gut microbiome, biomarkers of gut health and cardiometabolic health after consuming fermented and unfermented cabbage.

The main questions it aims to answer are:

Does eating kimchi (fermented cabbage) result in enrichment of lactic acid bacteria in the stools of participants? Does eating kimchi result in metabolic changes in the gut microbiome, biomarkers of gut and cardiometabolic health of participants? Researchers will compare a group of participants eating fermented cabbage (kimchi) daily to a group of participants eating non-fermented cabbage daily.

Participants will:

Eat kimchi or cabbage daily for 3 weeks. Visit the study site for brief visits up to 5 times. Have blood drawn and provide a fecal sample 2 times - at beginning and end of the 3 week study.

Keep occasional records of food intake and questionnaires about any gastrointestinal symptoms that participants may have.

02

Conditions studied

  • Healthy Adult Participants

Keywords

  • Healthy adult
  • GI health
  • Fermented food
03

In context

Lead sponsor

University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.

Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI of 25-30 kg/m2
  • No or occasional consumption of kimchi (3 or fewer times per week)
  • Willing to eat study food every day for 3 weeks
  • Willing to participate in study protocols

Exclusion criteria

Exclusion Criteria:

  • Allergy to cabbage and /or cruciferous family vegetables
  • Allergy to kimchi ingredients such as shellfish and fish sauce
  • Daily consumption of kimchi
  • Diagnosed digestive issues such as irritable bowel syndrome (IBS) or gastrointestinal inflammatory bowel disease (IBD) or conditions such as Crohn's disease
  • Previous bowel surgery that disrupts the digestive flow, motility or gastric emptying process
  • Antibiotics used in the 2 months prior to enrollment
  • Unwillingness to discontinue probiotics during study and washout period
  • Active diagnosis and/or treatment for cancer
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Kimchi

    Other: 60 grams per day of intervention food

  • Active comparator
    Cabbage

    Other: 60 grams per day of intervention food

Interventions

  • Other60 grams per day of intervention food

    Non-fermented cabbage

  • Other60 grams per day of intervention food

    Kimchi fermented cabbage

06

What researchers measure

Primary outcomes

  1. Change from baseline in fecal Lactic Acid Bacteria (LAB)

    Time frame: Baseline and week 3

Secondary outcomes

  1. Fecal Metabolites - Change in short chain fatty acids (SCFA) and secondary bile acids (BA)

    Time frame: Baseline and 3 weeks

  2. Gut integrity and health - Change in fecal calprotectin, fecal lipocalin, and fecal sIGA

    Time frame: Baseline and 3 weeks

  3. Gut integrity and health - Change in plasma lipopolysaccharide binding protein (LBP), lipopolysaccharide (LPS), zonulin, and sCD14

    Time frame: Baseline and 3 weeks

  4. Immune biomarkers - Change in plasma IL-6, TNF-alpha, hsCRP

    Time frame: Baseline and 3 weeks

  5. Cardiometabolic biomarkers - Change in lipid panel (TC, LDL, HDL, TG), and oxidized LDL (oxLDL)

    Time frame: Baseline and 3 weeks

  6. Qualitative self-assessment of gut associated health - Change in Gastrointestinal Symptom Rating Scale (GSRS)

    This questionnaire rates gastrointestinal symptoms over the past 7 days. A higher score indicates presence and increasing severity of symptoms and level of discomfort.

    Time frame: Baseline and 3 weeks

  7. Qualitative self-assessment of gut associated health - Change in Digestion-associated Quality of Life Questionnaire (DQLQ)

    This questionnaire measures the effect of digestive symptoms on daily life over the past 7 days. A higher score indicates a lower (worse) digestion-associated Quality of Life.

    Time frame: Baseline and 3 weeks

Other outcomes

  1. Body Mass Index (BMI)

    To derive the Body Mass Index (BMI) the following will be done: Height will be measured in meters. Weight will be measured in kilograms. These values will be aggregated to arrive at one reported value to report BMI in kg/m2

    Time frame: Baseline and 3 weeks

  2. Dietary Records and nutritional analysis of Macronutrients

    ASA24 (Automated Self Assessment of diet on the NIH website) will be used to record 24 hours of diet intake. Macronutrients will be measured in grams/day.

    Time frame: Baseline, week 1 of intervention, week 3 of intervention

  3. Dietary records and assessment of Fiber intake

    ASA24 (Automated Self Assessment of diet on the NIH website) will be used to record 24 hours of diet intake. Dietary fiber will be measured in grams/day.

    Time frame: Baseline, weeks 1 and 3

  4. Waist Circumference

    Waist circumference will be measured in centimeters

    Time frame: Baseline and 3 weeks

  5. Blood Pressure

    Blood pressure will be measured by automated upper arm cuff to read systolic and diastolic pressure in units of mm Hg. Normal pressure is considered 120/80 mm Hg.

    Time frame: Baseline and 3 weeks

07

Study locations

2 of 2 sites recruiting
  • Ragle Human Nutrition Center
    Davis, California 95616, United States
    Recruiting
  • UC Davis Ragle Human Nutrition Research Center
    Davis, California 95616, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07435831
Lead sponsor
University of California, Davis
Responsible party
Sponsor
First posted
Feb 27, 2026
Start date
Mar 30, 2026
Primary completion
Jan 30, 2027 (estimated)
Completion
Dec 2029 (estimated)
Last update
Apr 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion